antibodies    austin    berkeley    biology    bristol-myers squibb    cancer    cell signaling    checkpoint inhibitor    chemotherapy    immune checkpoint blockade    immune checkpoint therapy    immune system    immunology    immunotherapy    immunotherapy platform    ipilimumab    james p. allison    kyoto university    lymphocytes    md anderson center    medarex    melanoma    nobel prize    paul ehrlich    pd-1    programmed cell death protein 1    q&a    t cells    tasuku honjo    university of california    university of texas    willie nelson